Understanding the health-related quality of life and treatment-related side-effects in patients who have been in remission from testicular cancer for 12-24 months.

ABSTRACT:

Introduction

Despite the excellent long-term prognosis after treatment for testicular cancer (TCa), therapy-related side effects can be persistent and severe. The aim of this study was to determine the nature and prevalence of post-treatment symptoms and their impact on health-related quality of life (HRQoL) in TCa patients 12 to 24 months after treatment.

Materials and methods

Cross-sectional, single-center study. All patients who were aged 18 and over, had completed TCa treatment 12-24 months previously and had no evidence of disease recurrence were considered eligible. Participants were stratified into four groups: 1) orchidectomy only; 2) orchidectomy and single dose adjuvant carboplatin; 3) multi-agent induction chemotherapy (CBOP-BEP, BEPx3 or x4, or Epx4 regimens); an

SUBMITTER: Cazzaniga W 

PROVIDER: S-EPMC12327304 | biostudies-literature | 2023

REPOSITORIES: biostudies-literature